Intrachain disulfide bonds between paired cysteines in the glycoprotein (G) of vesicular stomatitis virus (VSV) are required for the recognition of discontinuous epitopes by specific monoclonal antibodies (MAbs) (W. Keil and R. R. Wagner, Virology 170:392-407, 1989). Cleavage by Staphylococcus aureus V8 protease of the 517-amino-acid VSV-New Jersey G protein, limited to the glutamic acid at residue 110, resulted in a protein (designated G.) with greatly retarded migration by polyacrylamide gel electrophoresis (PAGE) under nonreducing conditions. By Western blot (immunoblot) analysis, protein GV8 was found to lose discontinuous epitope IV, which maps within the first 193 NH2-terminal amino acids. These data, coupled with those obtained by PAGE migration of a vector-expressed, truncated protein (G-1.93) under reducing and nonreducing conditions, lead us to postulate the existence of a major loop structure within the first 193 NH2-terminal amino acids of the G protein, possibly anchored by a disulfide bond between cysteine 108 and cysteine 169, encompassing epitope IV. Site-directed mutants in which 10 of the 12 cysteines were individually converted to serines in vaccinia virus-based vectors expressing these single-site mutant G proteins were also constructed, each of which was then tested by immunoprecipitation for its capacity to recognize epitope-specific MAbs. These results showed that mutations in NH2-terminal cysteines 130, 174, and, to a lesser extent, 193 all resulted in the loss of neutralization epitope VIII. A mutation at NH2-terminal cysteine 130 also resulted in the loss of neutralization epitope VII, as did a mutation at cysteine 108 to a lesser extent. Both epitopes VII and VIII disappeared when mutations were made in COOH-distal cysteine 235, 240, or 273, the general map locations of epitopes VII and VIII. These studies also reveal that distal, as well as proximal, cysteine residues markedly influence the disulfide-bond secondary structure, which ostensibly determines the conformational structure of the VSV-New Jersey G protein required for presentation of the major discontinuous epitopes recognized by neutralizing MAbs.
The virion membrane glycoprotein (G) of vesicular stomatitis virus (VSV) serves as a model system for studying the synthesis, processing, and membrane insertion of eucaryotic glycoproteins (19, 22) . The G protein is also both the major organ for recognition and adsorption of VSV to the surface of host cells (1, 3) and the serotypic viral antigen that gives rise to and reacts with neutralizing antibodies (9) . Bricker et al. (2) have raised monoclonal antibodies (MAbs) that recognize at least nine independent epitopes on the G protein of the New Jersey serotype of VSV (VSV-NJ). By expressing deletion mutants and chimeras of recombinant G proteins, we have mapped the binding affinity of conformation-dependent, neutralizing MAbs to the central region of the 517-amino-acid VSV-NJ G protein, extending from amino acid residues 193 to 289 (8) . Also demonstrated in these studies was the existence of a conformational but nonneutralization region (designated epitope IV) within the first 193 NH2-terminal amino acids. The reduced form of the VSV-NJ G protein could not recognize neutralizing and some nonneutralizing MAbs reactive with conformational epitopes, indicating that disulfide bonds play a key role in defining the discontinuous epitopes of the VSV-NJ G protein (8) . As defined by Laver et al. (10) , the term discontinuous "is a more accurate description of nonlinear epitopes since they are assembled from several different portions of the polypeptide chain." VSV glycoproteins of both serotypes have 12 highly conserved cysteine residues (5) . To date, no data on the location of disulfide bonds between paired cysteine residues that determine the secondary structure defining the discontinuous conformational epitopes of VSV-NJ G protein have been provided. To this end, we performed two types of experiments designed to locate the likely pairs among the 12 cysteine residues that would define the discontinuous epitopes for recognition of neutralizing MAbs. In the first experiments, we located the potential disulfide-forming cysteine residues in a limited protease-digested peptide reactive by Western blotting (immunoblotting) with specific MAbs and mapped by NH2-terminal amino acid sequencing. In the second experimental approach, we located cysteine residues and specific epitopes in unreduced truncated segments or site-directed mutants of VSV-NJ G protein expressed by a vaccinia virus vector and immunoprecipitated by epitopespecific MAbs.
MATERIALS AND METHODS
Viruses and cells. The VSV-NJ serotype (Ogden strain) propagated in BHK-21 cells was isolated and purified as previously described (6, 16) . The vaccinia virus recombinant expressing the bacteriophage T7 RNA polymerase gene (4) was kindly supplied by Bernard Moss V8 protease digestion of VSV glycoprotein. The VSV-NJ G protein was isolated from virions as previously described (18) . Briefly, purified virions were resuspended in 1 ml of 50 mM Tris-HCl buffer (pH 8.0) at a concentration of 0.5 to 1.0 mg/ml and exposed for 1 h at room temperature to the dialyzable nonionic detergent 3-octylglucoside (Calbiochem, La Jolla, Calif.). After removal of the nucleocapsids by centrifugation at 150,000 x g, the supernatant fluid was dialyzed for 12 to 14 h at 4°C against repeated changes of 10 mM Tris-HCl (pH 7.8), and the detergent-free G protein was concentrated to a protein concentration of 2 to 3 mg/ml in Centricon (Amicon).
Time-limited fragmentation of the VSV-NJ G protein was conducted with TN buffer (100 mM NaCl, Tris-HCl [pH 7.5]) in the presence of 0.1% sodium dodecyl sulfate (SDS) (final concentration). The standard protease reaction was carried out with appropriate amounts of Staphylococcus aureus V8 protease (Pierce) diluted in a final 50-,ul volume of TN buffer containing 10 to 15 ,ug of purified G protein. Protease digestion was terminated after a period of incubation by adding 20 ,ul of 3 x TN buffer to each sample, and each sample was then loaded onto polyacrylamide-SDS gels for electrophoretic separation of the resulting peptides. These V8-generated peptides were blotted onto nitrocellulose filters (Millipore) and, where appropriate, NH2-terminal amino acids were sequenced with the aid of an Applied Biosystems 470A Sequencer (7).
Plasmids. The basic vector used to express the entire or truncated VSV-NJ G protein, as well as its site-directed mutants, was pWK9 (8), which was derived from the vector pTF7IHB-1 containing the phage T7 promoter and terminator sequences constructed by Fuerst et al. (4) . The pWK9 plasmid is actually a hybrid, since the N-terminal 43 amino acids were derived from the G gene of VSV-Indiana (VSVInd) and are virtually identical to the comparable amino acid sequences of VSV-NJ; this pWK9 plasmid was used because its expression is far superior to that of the recombinant VSV-NJ G gene (8) . Expression of this plasmid and similar pTF plasmids requires coinfection with the vaccinia virus recombinant vTF1-6,2, which expresses the phage T7 polymerase. To create a truncated pWK9 G gene expressing the first 193 amino acids of the VSV-NJ G protein (G1193), we created an NcoI site overlapping the ATG codon at position 1 of the coding region of pWK9 by employing polymerase chain reaction technology (Gene Amp; U.S. Biochemicals). The truncated G gene was excised from this recombinant by exposure to restriction enzymes NcoI and PstI, and the resulting 576-bp fragment was inserted into the identical site of the cap-independent vector pTM1, also driven by the phage T7 polymerase promoter (17) , kindly supplied by Bernard Moss. This new plasmid was designated pPG7 and expressed the truncated VSV-NJ G protein G1193. A polypeptide expressing the first 411 amino acids of the VSV-NJ G protein was also constructed. This construct was derived from the VSV-NJ G gene plasmid pNJ-G2 of Gallione and Rose (5) by cloning a PstI-AccI fragment (blunt ended in the AccI site with T4 polymerase before treatment with PstI) into the PstI-StuI sites of plasmid pPG7 described above; this construct was designated pPG8 and expressed the truncated VSV-NJ G protein Gl411.
A vector expressing the carboxy-terminal amino acids 193 through 517 of the VSV-NJ G protein was constructed from plasmid pCL5, which was originally made by cloning a PstI fragment of plasmid pNJ-G2 of Gallione and Rose (5 showing the map locations of cysteine residues (@), the major V8 protease cleavage site (ft ) with relevant amino acid sequences, and the N-linked carbohydrate chain at residue 179 (0) and the approximate map locations of epitopes IV, VII, and VIII. (A) Purified VSV-NJ virions were resuspended in sample buffer containing 3% SDS and aliquots exposed to increasing concentrations of P-mercaptoethanol. The (21) . Figure 1B shows the electropherogram profile of products generated by limited and progressive digestion of VSV-NJ G protein by V8 protease under nonreducing conditions. After the exposure of G protein to V8 protease at V8/G ratios of 1:100 or 1:50 (Fig. 1B, lanes 3 and 4) , a band designated GV8 that migrates more slowly than the untreated G protein appears (Fig. 1B, lane 2) . At increasing concentrations of V8 protease at V8/G ratios of 1:20 and 1:10 ( Fig. IB, lanes 5 and  6) , low-molecular-weight G peptides appear, with the concomitant disappearance of the high-molecular-weight G protein.
The retarded migration of G protein resulting from limited V8 protease digestion (Fig. 1B, lane 3 For future reference, Fig. 1C also shows the relative positions on the stick model of the 12 cysteines and three discontinuous epitopes (IV, VII, and VIII) in relation to the putative V8 cleavage site in the amino-proximal two-thirds of the VSV-NJ G protein.
Comparative affinity of GV8 for binding epitope-specific
MAbs. It was of interest to determine whether the single cleavage site at Glu-110 made by 0.1 pg of V8 protease would alter the conformation of G protein sufficiently to abolish specific conformational antigenic determinants (epitopes). As previously described (8) and as summarized in the legend to Fig. 1 To determine whether the conformationally altered GV8 protein loses the capacity to bind these MAbs, purified VSV-NJ G protein (10 ,ug) was exposed to 0.1 ,ug of V8 protease (V8/G ratio, 1:100), as shown in Fig. 1B Although neutralization epitopes VII and VIII had previirected to epitope III). The ously been mapped to a region between amino acids 193 and of the three truncated G 289 of the VSV-NJ G protein (8) , it was important to ning gel buffers and treated determine whether the cysteine residues located within the (epitope VIII) followed by SDS-PAGE and autoradiography.
The electropherogram data shown in Fig. 3B reveal that all four epitopes are present in the entire G protein expressed f whether cysteine resiby pWK9, as determined by immunoprecipitation with each rminal amino acids form of the four MAbs (Fig. 3B, upper panel) . In sharp contrast, dimensional structure of protein G193 517 (expressed by pCL5) was immunoprecipignition of discontinuous tated only by MAb 8 directed to epitope III (Fig. 3B, MAbs 14 and 15 . These data collectively suggest that the discontinuous and neutralization epitopes VII and VIII depend, at least to some extent, on the conformation of G protein provided by disulfide bonds emanating from cysteine residues amino proximal to the region at which these epitopes map.
DISCUSSION
Our laboratory has undertaken the mapping of the antigenic determinants of the type-specific G protein of VSV, particularly those of VSV-NJ, which is the primary etiologic agent of enzootic and epizootic diseases in cattle and swine (15) . Despite being handicapped by not having a threedimensional crystallographic structure of the G protein, we started by raising MAbs directed to nine nonoverlapping epitopes, many of which mapped by crude protease-digestion techniques to the central third of the 517-amino-acid VSV-NJ G protein (2) . The map locations of the epitopes were greatly refined by determining the binding affinities of epitope-specific MAbs to expressed deletions, truncations, and chimeras of the VSV-Ind and VSV-NJ G proteins (8) . The general map locations of neutralization epitopes V, VI, VII, and VIII were confirmed by the binding of MAbs to neutralization-escape mutants of VSV-NJ and sequencing the mutant G genes (11) . Additional confirmatory data were obtained by sequencing G gene mutants spontaneously arising in diseased cattle and swine (12) . Experiments were also performed to determine the effect, if any, of glycosylation on the conformational G protein epitopes of VSV-NJ grown in the presence of tunicamycin (6) . These experiments suggested that the loss of antigenic determinants on unglycosylated G protein was probably due to aberrant folding leading to altered conformation, presumably resulting from the mismatched formation of disulfide bonds in G proteins defective in N-linked glycosylation, as proposed by Machamer and Rose (14) . These background studies led us to embark on the experiments reported here, which were designed to determine the contribution of each cysteine residue to disulfide bond formation, resulting in the correct secondary structure and conformation required for recognition by MAbs of certain VSV-NJ G protein epitopes. A somewhat unexpected finding of these studies resulted from limited digestion with S. aureus V8 protease, which converted purified G protein to a more slowly migrating form (GV8) on PAGE; amino acid sequencing revealed that GV8 was cleaved at a single site between Glu-110 and Ala-111. This Cys->Ser substitutions in the same regions. (ii) The map locations assigned to the discontinuous epitopes altered by Cys--Ser substitutions are quite compatible with the locations of these epitopes in expressed truncated G proteins G1193 and G193 517 (Fig. 3) . (iii) The results of immunoprecipitation experiments shown in Fig. 4 clearly demonstrate that a mutation in Cys-108 affects only epitope IV, whereas a mutation in the adjacent cysteine (Cys-130) results in the loss of epitope VIII but not that of epitope IV. (iv) Although defective glycosylation of glycoproteins and aberrant disulfide bond formation seem to be closely related events (24) , we had previously shown that the failure to glycosylate nascent VSV-NJ G protein at asparagine 179 results in the loss of epitope VII but not that of the closely adjacent epitope VIII (6) . Our experiments reported here show the opposite effect, i.e., the loss of epitope VIII but not that of epitope VII when mutations were made in Cys-174 and Cys-193 quite close to the glycosylation site at residue 179.
Clearly, crystallographic studies to define the three-dimensional structure of VSV-NJ G protein are required to confirm or modify the partial model proposed here, which is largely based on putative cysteine pairing and disulfide bond secondary structure.
